Convalescent plasma therapy

Print

Mayo Clinic's approach

Collaboration

Mayo Clinic joined with medical centers across the U.S. to collect plasma from people who had recovered from COVID-19. Mayo Clinic coordinated this government-sponsored program.

Team approach

Mayo doctors from many areas work together to study potential treatments for COVID-19. Team member specialties include:

  • Infectious diseases.
  • Laboratory medicine and pathology.
  • Blood collection and testing (transfusion medicine).
  • Pharmacy.
  • Virus studies (virology).
  • Cardiovascular diseases.
  • Primary Care.
  • Department of Nursing.
  • Department of Pharmacy.
  • Infusion Therapy Centers.

Research

Mayo Clinic researchers are studying the virus that causes COVID-19 and how it affects the immune system. They're studying drugs and treatments for COVID-19 as well as working on diagnostic and antibody tests. Researchers are active in clinical trials for COVID-19 and other infectious diseases.

By Mayo Clinic Staff
Doctors & Departments
July 21, 2023
Print
  1. Investigational COVID-19 convalescent plasma. U.S. Food and Drug Administration. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/investigational-covid-19-convalescent-plasma. Accessed May 2, 2023.
  2. Hoffman R, et al. Principles of plasma and plasma derivatives. In: Hematology. 8th edition. Elsevier. 2023. https://www.clinicalkey.com. Accessed May 2, 2023.
  3. Marano G, et al. Convalescent plasma: New evidence for an old therapeutic tool? Blood Transfusion. 2016; doi:10.2450/2015.0131-15.
  4. Emergency use authorization. U.S. Food and Drug Administration. https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization. Accessed May 2, 2023.
  5. AskMayoExpert. Convalescent Plasma. Mayo Clinic; 2023.
  6. COVID-19 convalescent plasma. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/therapies/antivirals-including-antibody-products/covid-19-convalescent-plasma/. Accessed May 2. 2023.
  7. Rajendran K, et al. Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. Journal of Medical Virology. 2020; doi:10.1002/jmv.25961.
  8. Senefeld JW, et al. COVID-19 Convalescent plasma for the treatment of immunocompromised patients: A systematic review and meta-analysis. Journal of the American Medical Association: Network Open. 2023; doi:10.1001/jamanetworkopen.2022.50647.
  9. COVID-19 treatments and medications. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html. Accessed May 2, 2023.
  10. Kim AR. Coronavirus disease 2019 (COVID-19): Management in hospitalized adults. https://www.uptodate.com/contents/search. Accessed May 2, 2023.
  11. Infectious disease, HLA and ABO donor qualification testing. American Red Cross. https://www.redcrossblood.org/biomedical-services/blood-diagnostic-testing/blood-testing.html. Accessed May 3, 2023.
  12. Tulledge-Scheitel, S (expert opinion). Mayo Clinic. May 5, 2023.

Related

Products & Services

Convalescent plasma therapy